The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
The global Bronchodilators market was valued at US$ 31140 million in 2023 and is anticipated to reach US$ 42270 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
This report aims to provide a comprehensive presentation of the global market for Bronchodilators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchodilators.
Report Scope
The Bronchodilators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bronchodilators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bronchodilators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- AstraZeneca
- Boehringer Ingelheim
- GlaxoSmithKline
- F. Hoffmann-La Roche
Segment by Type
- Anticholinergic Bronchodilators
- Adrenergic Bronchodilators
- Bronchodilator Combinations
- Methylxanthines
Segment by Application
- Asthma
- COPD
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bronchodilators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bronchodilators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Bronchodilators Market Overview
1.1 Product Overview and Scope of Bronchodilators
1.2 Bronchodilators Segment by Type
1.2.1 Global Bronchodilators Market Value Comparison by Type (2024-2030)
1.2.2 Anticholinergic Bronchodilators
1.2.3 Adrenergic Bronchodilators
1.2.4 Bronchodilator Combinations
1.2.5 Methylxanthines
1.3 Bronchodilators Segment by Application
1.3.1 Global Bronchodilators Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Bronchodilators Market Size Estimates and Forecasts
1.4.1 Global Bronchodilators Revenue 2019-2030
1.4.2 Global Bronchodilators Sales 2019-2030
1.4.3 Global Bronchodilators Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bronchodilators Market Competition by Manufacturers
2.1 Global Bronchodilators Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bronchodilators Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bronchodilators Average Price by Manufacturers (2019-2024)
2.4 Global Bronchodilators Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bronchodilators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bronchodilators, Product Type & Application
2.7 Bronchodilators Market Competitive Situation and Trends
2.7.1 Bronchodilators Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bronchodilators Players Market Share by Revenue
2.7.3 Global Bronchodilators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bronchodilators Retrospective Market Scenario by Region
3.1 Global Bronchodilators Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bronchodilators Global Bronchodilators Sales by Region: 2019-2030
3.2.1 Global Bronchodilators Sales by Region: 2019-2024
3.2.2 Global Bronchodilators Sales by Region: 2025-2030
3.3 Global Bronchodilators Global Bronchodilators Revenue by Region: 2019-2030
3.3.1 Global Bronchodilators Revenue by Region: 2019-2024
3.3.2 Global Bronchodilators Revenue by Region: 2025-2030
3.4 North America Bronchodilators Market Facts & Figures by Country
3.4.1 North America Bronchodilators Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bronchodilators Sales by Country (2019-2030)
3.4.3 North America Bronchodilators Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bronchodilators Market Facts & Figures by Country
3.5.1 Europe Bronchodilators Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bronchodilators Sales by Country (2019-2030)
3.5.3 Europe Bronchodilators Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bronchodilators Market Facts & Figures by Country
3.6.1 Asia Pacific Bronchodilators Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bronchodilators Sales by Country (2019-2030)
3.6.3 Asia Pacific Bronchodilators Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bronchodilators Market Facts & Figures by Country
3.7.1 Latin America Bronchodilators Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bronchodilators Sales by Country (2019-2030)
3.7.3 Latin America Bronchodilators Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bronchodilators Market Facts & Figures by Country
3.8.1 Middle East and Africa Bronchodilators Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bronchodilators Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bronchodilators Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bronchodilators Sales by Type (2019-2030)
4.1.1 Global Bronchodilators Sales by Type (2019-2024)
4.1.2 Global Bronchodilators Sales by Type (2025-2030)
4.1.3 Global Bronchodilators Sales Market Share by Type (2019-2030)
4.2 Global Bronchodilators Revenue by Type (2019-2030)
4.2.1 Global Bronchodilators Revenue by Type (2019-2024)
4.2.2 Global Bronchodilators Revenue by Type (2025-2030)
4.2.3 Global Bronchodilators Revenue Market Share by Type (2019-2030)
4.3 Global Bronchodilators Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bronchodilators Sales by Application (2019-2030)
5.1.1 Global Bronchodilators Sales by Application (2019-2024)
5.1.2 Global Bronchodilators Sales by Application (2025-2030)
5.1.3 Global Bronchodilators Sales Market Share by Application (2019-2030)
5.2 Global Bronchodilators Revenue by Application (2019-2030)
5.2.1 Global Bronchodilators Revenue by Application (2019-2024)
5.2.2 Global Bronchodilators Revenue by Application (2025-2030)
5.2.3 Global Bronchodilators Revenue Market Share by Application (2019-2030)
5.3 Global Bronchodilators Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Bronchodilators Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Bronchodilators Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Bronchodilators Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Bronchodilators Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Bronchodilators Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Bronchodilators Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Bronchodilators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Bronchodilators Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bronchodilators Industry Chain Analysis
7.2 Bronchodilators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bronchodilators Production Mode & Process
7.4 Bronchodilators Sales and Marketing
7.4.1 Bronchodilators Sales Channels
7.4.2 Bronchodilators Distributors
7.5 Bronchodilators Customers
8 Bronchodilators Market Dynamics
8.1 Bronchodilators Industry Trends
8.2 Bronchodilators Market Drivers
8.3 Bronchodilators Market Challenges
8.4 Bronchodilators Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
